Ligand-independent dimerization of the human prolactin receptor isoforms: Functional implications

Molecular Endocrinology

Volumn 20, Issue 11, 2006, Pages 2734-2746

  Gadd, Samantha L ^a   Clevenger, Charles V ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; PROLACTIN RECEPTOR;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; DIMERIZATION; IMMUNOPRECIPITATION; LIVER CARCINOMA; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CERCOPITHECUS AETHIOPS; CHO CELLS; COS CELLS; CRICETINAE; DIMERIZATION; HUMANS; LIGANDS; MEMBRANE PROTEINS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN DENATURATION; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, PROLACTIN; SIGNAL TRANSDUCTION; TRANSFECTION; YEASTS;

MAMMALIA;

EID: 33751526473     PISSN: 08888809     EISSN: 08888809     Source Type: Journal    
DOI: 10.1210/me.2006-0114     Document Type: Article

References (57)

1. Kelly PA, Ali S, Rozakis M, Goujon L, Nagano M, Pellegrini I, Gould D, Djiane J, Edery M, Finidori J, Postel-Vinay MC 1993 The growth hormone/prolactin receptor family. Rec Prog Horm Res 48:123-164
2. Shiu RPC, Murphy LC, Tsuyuki D, Myal Y, Lee-Wing M, Iwasiow B 1987 Biological actions of prolactin in human breast carcinoma. Recent Prog Horm Res 43:277-299
3. Bazan JF 1990 Haematopoietic receptors and helical cytokines. Immunol Today 11:350-354
4. Chang W-P, Ye Y, Clevenger CV 1998 Stoichiometric structure/function analysis of the prolactin receptor signaling domains by receptor chimeras. Mol Cell Biol 18:896-905
5. Campbell GS, Argetsinger LS, Ihle JN, Kelly PA, Rillema JA, Carter-Su C 1994 Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants. Proc Natl Acad Sci USA 91:5232-5236
6. Rui H, Lebrun J-J, Kirken RA, Kelly PA, Farrar WL 1994 JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization. Endocrinology 135:1299-1306
7. Kline JB, Rycyzyn MA, Clevenger CV 2002 Characterization of a novel and functional human prolactin receptor isoform (ΔS1PRLr) containing only one fibronectin-like domain. Mol Endocrinol 16:2310-2322
8. fyn is associated with prolactin receptor and is activated by prolactin stimulation of T-lymphocytes. Mol Endocrinol 8:674-681
9. Acosta JJ, Munoz RM, Gonzalez L, Subtil-Rodriguez A, Dominguez-Caceras MA, Garcia-Martinez JM, Calcabrini A, Lazaro-Trueba I, Martin-Perez J 2003 Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways. Mol Endocrinol 17:2268-2282
10. Goupille O, Daniel N, Bignon C, Jolivet J, Djiane J 1997 Prolactin signal transduction to milk protein genes: carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation. Mol Endocrinol 127:155-169
11. Clevenger CV, Torigoe T, Reed JC 1994 Prolactin induces rapid phosphorylation and activation of prolactin receptor associated Raf-1 kinase in a T-cell line. J Biol Chem 269:5559-5565
12. Erwin RA, Kirken RA, Malbarba MG, Farrar WL, Rui H 1995 Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless. Endocrinology 136:3512-3518
13. Sundstrom M, Lundqvist T, Rodin J, Giebel LB, MIlligan D, Norstedt G 1996 Crystal structure of an antagonist mutant of the human growth hormone, G120R, in complex with its receptor at 2.9 A resolution. J Biol Chem 271:32197-32203
14. Clevenger CV, Ngo W, Luger SM, Gewirtz AM 1995 Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line. J Biol Chem 270:13246-13253
15. Clevenger CV, Thickman K, Ngo W, Chang W-P, Takayama S, Reed JC 1997 Role of Bag-1 in the survival and proliferation of the cytokine-dependent lymphocyte lines, Ba/F3 and Nb2. Mol Endocrinol 11:608-618
16. Clevenger CV, Sillman AL, Hanley-Hyde J, Prystowsky MB 1992 Requirement for prolactin during cell cycle regulated gene expression in cloned T-lymphocytes. Endocrinol 130:3216-3222
17. Yu-Lee L-Y 1990 Prolactin stimulates transcription of growth-related genes in Nb2 T lymphoma cells. Mol Cell Endocrinol 68:21-28
18. Harding P, Wang X, Okada S, Chen WY, Wan W, Kopchick JJ 1996 Growth hormone and a GH antogonist promote GH receptor dimerization and internalization. Bioessays 271:6708-6712
19. Perrot-Applanet M, Gualillo O, Pezet A, Vincent V, Edery M, Kelly PA 1997 Dominant negative and cooperative effects of mutant forms of prolactin receptor. Mol Endocrinol 11:1020-1032
20. Bazan JF 1990 Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87:6934-6938
21. Kline JB, Roehrs H, Clevenger CV 1999 Functional characterization of the intermediate isoform of the human prolactin receptor. J Biol Chem 274:35461-35468
22. Kinet S, Bernichtein S, Kelly PA, Martial JA, Goffin V 1999 Biological properties of human prolactin analogs depend not only on global hormone affinity, but also on the relative affinities of both receptor binding sites. J Biol Chem 274:16033-26043
23. Hu Z, Meng J, Dufau ML 2001 Isolation and characterization of two novel forms of the human prolactin receptor generated by alternative splicing of a newly identified exon 11. J Biol Chem 276:41086-41094
24. Trott JF, Hovey RC, Koduri S, Vonderhaar BK 2003 Alternative splicing to exon 11 of human prolactin receptor gene results in multiple isoforms including a secreted prolactin-binding protein. J Mol Endocrinol 30:31-47
25. Tan D, Johnson DA, Wu W, Zeng L, Chen YH, Chen WY, Vonderhaar BK, Walker AM 2005 Unmodified prolactin (PRL) and S179D Prl-initiated bioluminescence resonance energy transfer between homo - and hetero - pairs of long and short human PRL receptors in living human cells. Mol Endocrinol 19:1291-1303
26. Kline JB, Clevenger CV 2001 Identification and characterization of the prolactin-binding protein (PRLBP) in human serum and milk. J Biol Chem 276:24760-24766
27. Lu JC, Piazza TM, Schuler LA 2005 Proteasomes mediate prolactin-induced receptor down-regulation and fragment generation in breast cancer cells. J Biol Chem 280:33909-33916
28. Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, Barnard R, Waters MJ, Wood WI 1987 Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 330:537-543
29. Sotiropoulos A, Goujon L, Simonin G, Kelly PA, Postel-Vinay MC, Finidori J 1993 Evidence for generation of the growth hormone-binding protein through proteolysis of the growth hormone membrane receptor. Endocrinology 132:1863-1865
30. Alele J, Jiang J, Goldsmith JF, Yang X, Maheshwari HG, Black RA, Baumann G, Frank SJ 1998 Blockade of growth hormone receptor shedding by a metalloprotease inhibitor. Endocrinology 139:1927-1935
31. Zhang Y, Jiang J, Black RA, Baumann G, Frank SJ 2000 Tumor necrosis factor-α converting enzyme (TACE) is a growth hormone binding protein (GHBP) sheddase: the metalloprotease TACE/ADAM-17 is critical for (PMA-induced) GH receptor proteolysis and GHBP generation. Endocrinology 141:4342-4348
32. Cowan JW, Wang X, Guan R, He K, Jiang J, Baumann G, Black RA, Wolfe MS, Frank SJ 2005 Growth hormone receptor is a target for presenilin-dependent γ-secretase cleavage. J Biol Chem 280:19331-19342
33. Somers W, Ultsch M, de Vos AM, Kossiakoff AA 1994 The X-ray structure of a growth hormone-prolactin receptor complex. Nature 372:478-481
34. Gertler A, Grosclaude J, Strasburger CJ, Nir S, Djiane J 1996 Real-time measurements of the interactions between lactogenic hormones and prolactin-receptor extracellular domains from several species support the model hormone-induced transient receptor dimerization. J Biol Chem 271:24482-24491
35. Cunningham BC, Ultsch M, DeVoss AM, Mulkerrin MG, Clauser KR, Wells JA 1991 Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254:821-825
36. Ross RJM, Leung KC, Maamra M, Bennett W, Doyle N, Waters MJ, Ho KKY 2001 Binding and functional studies with the growth hormone receptor antagonist B2036-PEG (Pegvisomant), reveal effects of pegylation and evidence that it binds to a receptor dimer. J Clin Endocrinol Metab 86:1716-1723
37. Gent J, van Kerkhof P, Roza M, Bu G, Strous GJ 2002 Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis. Proc Natl Acad Sci USA 100:6
38. Syed RS, Reid SW, Cuiwei L, Cheetham JC, Aoki KH, Liu B, Zhan H, Osslund TD, Chirino AJ, Zhang H, Finer-Moore J, Elliot S, Sitney K, Katz BA, Matthews DJ, Wendoloski JJ, Egrie J, Stroud RM 1998 Efficiency of signaling through cytokine receptors depends critically on receptor orientation. Nature 395:511-516
39. Livnah O, Stura EA, Middleton SA, Johnson DL, Joliffe LK, Wilson IA 1999 Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 283:987-990
40. Brown RJ, Adams JJ, Pelekanos RA, Wan Y, McKinstry WJ, Palethorpe K, Seeber RM, Monks TA, Eidne KA, Parker MW, Waters MJ 2005 Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nat Struct Mol Biol 12:814-821
41. Constantinescu SN, Huang L-S, Nam H-S, Lodish HF 2001 The erythropoietin receptor cytosolic juxtamembrane domain contains an essential, precisely oriented, hydrophobic motif. Mol Cell 7:377-385
42. Kubatzky KF, Ruan W, Gurezka R, Cohen J, Kettelet R, Watowich SS, Neumann D, Langosch D, Klingmuller U 2001 Self assembly of the transmembrane domain promotes signal transduction through the erythropoietin receptor. Curr Biol 11:110-115
43. Kline JB, Moore DJ, Clevenger CV 2001 Activation and association of the Tec tyrosine kinase with the human prolactin receptor: mapping of a Tec/Vav1-receptor binding site. Mol Endocrinol 15:832-841
44. Clevenger CV, Chang WP, Ngo W, Pasha TL, Montone KT, Tomaszewski JE 1995 Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. Am J Pathol 146:695-705
45. Berlanga JJ, Garcia-Ruiz JP, Perrot-Applanat M, Kelly PA, Edery M 1997 The short form of the prolactin (PRL) receptor silences PRL induction of the beta-casein gene promoter. Mol Endocrinol 11:1448-1457
46. Flynn A, Whittington V, Goffin V, Uney J, Norman M 2004 A mutant receptor with enhanced dominant-negative activity for the blockade of human prolactin signaling. J Mol Endocrinol 32:385-396
47. Ruan W, Becker V, Klingmuller U, Langosch D 2004 The interface between self-assembling erythropoietin receptor transmembrane segments corresponds to a membrane-spanning leucine zipper. J Biol Chem 279:3273-3279
48. Mendrola JM, Berger MB, King MC, Lemmon MA 2002 The single transmembrane domains of ErbB receptors self-associate in cell membranes. J Biol Chem 277:4704-4712
49. Yu X, Sharma KD, Takahashi T, Iwamoto R, Mekada E 2002 Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling. Mol Biol Cell 13:2547-2557
50. de Vos AM, Ultsch M, Kossiakoff AA 1992 Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 255:306-312
51. Clackson T, Ultsch M, Well JA, de Vos AM 1998 Structural and functional analysis of the 1:1 growth hormone: receptor complex reveals the molecular basis for receptor affinity. J Mol Biol 277:1111-1128
52. Qazi AM, Tsai-Morris CH, Dufau ML 23 March 2006 Ligand-independent homo- and hetero- dimerization of the human prolactin receptor variants: inhibitory action of the short forms by heterodimerization. Mol Endocrinol 10.1210/me. 2005-0291
53. Biener E, Martin C, Daniel N, Frank SJ, Centonze VE, Herman B, Djiane J, Gertler A 2003 Ovine placental lactogen-induced heterodimerization of ovine growth hormone and prolactin receptors in living cells is demonstrated by fluorescence resonance energy transfer microscopy and leads to prolonged phosphorylation of signal transducer and activator of transcription (STAT) 1 and STAT3. Endocrinology 144:3532-3540
54. Chang WP, Clevenger CV 1996 Modulation of growth factor receptor function by isoform heterodimerization. Proc Natl Acad Sci USA 93:5947-5952
55. Chen WY, Ramamoorthy P, Chen N-Y, Sticca R, Wagner TE 1999 A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation Int J Oncol 17:1179-1185
56. Goffin V, Struman I, Mainfroid V, Kinet S, Martial JA 1994 Evidence for a second receptor binding site on human prolactin. J Biol Chem 269:32598-32606
57. Rycyzyn MA, Clevenger CV 2002 The intranuclear prolactin/ cyclophilin B complex as a transcriptional inducer. Proc Natl Acad Sci USA 99:6790-6795